Biotechnology is hot

Article Abstract:

Biotechnology is a hot area for investment Australia's strong international reputation in the area is attracting offshore money. Total investment has reached A$900 mil with revenues generated by core biotech companies in the year at an estimated A$1bil. Prices of biotech shares have ballooned in the past year. Price increases for shares of Cochlear, Peptech and CSI are discussed.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

The benefits of maturity

Article Abstract:

The overall philosophy of Vanguard Investments and its manager of interest rates Matthew McCrum is discussed along with cash management trusts and index managers.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Slowdown predicted for 2001

Article Abstract:

This article discusses economic forecasts for a slowdown in the Australian markets in 2001.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: